KRISTYN WONG: Open Payments
NPI 1518690908 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,226 in 114 payments from 17 companies in 2025. Trend: 2023 $1,412 · 2024 $2,664 · 2025 $3,226
Food & beverage: $3,175Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $506 |
| Janssen Biotech, Inc. | 14 | $493 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $473 |
| Lilly USA, LLC | 8 | $261 |
| Madrigal Pharmaceuticals | 8 | $238 |
| Regeneron Healthcare Solutions, Inc. | 6 | $183 |
| Gilead Sciences, Inc. | 7 | $180 |
| Intercept Pharmaceuticals, Inc. | 4 | $161 |
| Celltrion USA Inc. | 4 | $156 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $139 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, OMVOH, DUPIXENT, REZDIFFRA, OCALIVA, XIFAXAN.
Industry payments across FL — which companies pay providers there.
